Ranbaxy Laboratories Ltd (Merged)

  • Market Cap Cr.
  • Current Price 860
  • High & Low
  • Stock PE
  • Book Value 85.8
  • Dividend 0.00 %
  • ROCE 7.18 %
  • ROE -17.5 %
  • Face Value 5.00

About Ranbaxy Laboratories Ltd (Merged)

Ranbaxy Laboratories Ltd (Merged) is a prominent player in the industry, boasting a substantial market cap of ₹ Crore. The current share price stands at ₹ 860, with the stock having fluctuated between over the past year. The company's stock is priced at a P/E ratio of , indicating investor expectations of future growth.

Ranbaxy Laboratories Ltd (Merged)'s book value per share is ₹ 85.8, reflecting the company's net asset value. Despite a modest dividend yield of 0.00%, Ranbaxy Laboratories Ltd (Merged) demonstrates strong profitability metrics with a Return on Capital Employed (ROCE) of 7.18% and a Return on Equity (ROE) of -17.5%. The face value of each share is ₹ 5.00, which is the nominal value of the stock.